Retatrutide is an investigational triple incretin receptor agonist acting on GLP-1, GIP, and glucagon receptors currently undergoing clinical trials for the treatment of obesity and type 2 diabetes
The SIF was a commercially available product formulated according to pharmacopeial guidelines, consisting primarily of potassium dihydrogen phosphate (KHPO), sodium hydroxide for pH adjustment, and purified water, without digestive enzymes
Clemmons, David R., Sam Miller, and Jean-Claude Mamputu
Mechanisms of Antibiotic Resistance: Overview Bacterial resistance to antibiotics develops by intrinsic traits or by acquiring new genes or mutations
3,507 GLP-1RAs reduce liver fat accumulation by activating AMPK, which inhibits fatty acid synthesis enzymes and promotes fatty acid -oxidation, thus diminishing lipid droplet accumulation in hepatocytes